Skip to main content
. 2023 Mar 21;25(5):euad065. doi: 10.1093/europace/euad065

Table 3.

Incidence rate [95% confidence interval (CI)] of study endpoints according to pacing indication and AVH programming

Patients Endpoint Standard pacing AV hysteresis RRR P-value
Whole cohort Cardiac death 18/1296
1.4% (0.8–2.2) %
13/1296
1.0% (0.5–1.7) %
27.8% 0.366
Whole cohort HF hospitalizations 40/1296
3.1% (2.2–4.2) %
17/1296
1.3% (0.8–2.1) %
57.5% 0.002
Whole cohort a Persistent AF 67/870
7.7% (6.0–9.7) %
62/1169
5.3% (4.1–6.7) %
31.1% 0.028
SND Cardiac death 8/548
1.5% (0.6–2.9) %
5/629
0.8% (0.3–1.8) %
45.5% 0.276
SND HF hospitalizations 21/548
3.8% (2.4–5.8) %
11/629
1.7% (0.9–3.1) %
54.4% 0.028
SND a Persistent AF 32/251
12.7% (8.9–17.5) %
41/522
7.9% (5.7–10.5) %
38.4% 0.029
AV block Cardiac death 8/530
1.5% (0.7–3.0) %
6/444
1.4% (0.5–2.9) %
10.5% 0.836
AV block HF hospitalizations 10/530
1.9% (0.9–3.4) %
5/444
1.1% (0.4–2.6) %
40.3% 0.337
AV block a Persistent AF 22/488
4.5% (2.8–6.7) %
8/434
1.8% (0.8–3.6) %
60.0% 0.023
Other Cardiac death 2/218
0.9% (0.1–3.3) %
2/223
0.9% (0.1–3.2) %
2.2% 0.982
Other HF hospitalizations 9/218
4.1% (1.9–7.7) %
1/223
0.4% (0.0–2.5) %
89.1% 0.009
Othera Persistent AF 13/131
9.9% (5.4–16.4) %
13/213
6.1% (3.3–10.2) %
32.3% 0.193

AF, atrial fibrillation; AV, atrioventricular; HF, heart failure; RRR, risk rate ratio; SND, sinus node disease.

a

Patients without history of persistent/permanent AF at inclusion. Bold values indicate all the endpoints with P < 0.05.